Literature DB >> 25015

Human pharmacology studies with a new, orally active stimulant of cardiac adrenergic beta-receptors.

M Knaus, B Pfister, U C Dubach, P R Imhof.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 25015     DOI: 10.1016/0002-8703(78)90302-2

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


× No keyword cloud information.
  12 in total

1.  Haemodynamic and tolerance studies in man of a new, orally active, selective beta1-adrenoceptor agonist H 80/62.

Authors:  G Johnsson; L Jordö; P Lundborg; O Rönn; I Welin-Fogelberg; J Wikstrand
Journal:  Eur J Clin Pharmacol       Date:  1978-05-31       Impact factor: 2.953

2.  Differentiation of cardiac chronotropic and inotropic effects of beta-adrenoceptor agonists.

Authors:  E Carlsson; C G Dahlöf; A Hedberg; H Persson; B Tångstrand
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-11       Impact factor: 3.000

3.  The lack of a pronounced preference of prenalterol for the beta-l-adrenoceptor subtype.

Authors:  N Rohm; J Wagner; H J Schümann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980       Impact factor: 3.000

4.  Haemodynamic effects, plasma concentrations and tolerance of orally administered prenalterol in man.

Authors:  A Weiss; B Pfister; P Imhof; P H Degen; D Burckhardt; U C Dubach
Journal:  Eur J Clin Pharmacol       Date:  1980-11       Impact factor: 2.953

5.  Pharmacokinetics of prenalterol after single and multiple administration of controlled release tablets to patients with congestive heart failure.

Authors:  U Dahlström; C Graffner; U Jonsson; K J Hoffmann; E Karlsson; P O Lagerström
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

6.  Haemodynamic effects of a new beta 1-receptor agonist in acute myocardial infarction. A useful antidote to unwanted cardiac effects of beta-blocking agents.

Authors:  R Ariniego; F Waagstein; B Mombay; A Hjalmarson
Journal:  Br Heart J       Date:  1979-08

7.  Haemodynamic effects and pharmacokinetics of a new selective beta1-adrenoceptor agonist, prenalterol, and its interaction with metoprolol in man.

Authors:  O Rönn; C Graffner; G Johnsson; L Jordö; P Lundborg; J Wikstrand
Journal:  Eur J Clin Pharmacol       Date:  1979-02-19       Impact factor: 2.953

8.  Pharmacokinetic studies in man of the selective beta 1-adrenoceptor agonist, prenalterol.

Authors:  C Graffner; K J Hoffmann; G Johnsson; P Lundborg; O Rönn
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

9.  Effects of prenalterol on cardiac performance and transmural myocardial perfusion in patients with chronic renal failure.

Authors:  T Pedersen; K Cleemann-Rasmussen; I Brynjolf; H Ording; P E Nielsen; K Rasmussen
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

10.  Prenalterol, an oral beta-1 adrenoceptor agonist, in the treatment of chronic heart failure.

Authors:  D N Sharpe; R Coxon
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.